The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Compare

0 Followers

AIM Vaccine Co., Ltd. Class H (6660) Ownership Overview

0.03% Mutual Funds

0.40% ETFs

99.57% Public Companies and

Individual Investors

The ownership structure of AIM Vaccine Co., Ltd. Class H (HK:6660) stock is a mix of institutional, retail, and individual investors. , and 99.57% is owned by Public Companies and Individual Investors.

The ownership structure of AIM Vaccine Co., Ltd. Class H (HK:6660) stock is a mix of institutional, retail, and individual investors. Approximately 99.97% of the company’s stock is owned by Institutional Investors, 0.03% is owned by Insiders

Top Shareholders

# of Shares	Type	% Holding	Value
1,765,800	Institution	0.36%	1,223,699
186,400	Institution	0.04%	129,175
99,400	Institution	0.02%	68,884
49,000	Institution	<0.01%	33,957

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	99,400	Institution	0.02%	68,884
	49,000	Institution	<0.01%	33,957

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Core MSCI Emerging Markets ETF	1,423,800	Institution	0.29%	974,909
iShares MSCI China Small-Cap ETF	115,200	Institution	0.02%	78,880
iShares MSCI Emerging Markets Small Cap ETF	79,800	Institution	0.02%	54,641
SPDR S&P Emerging Markets Small Cap ETF	60,000	Institution	0.01%	41,220
SPDR EM Sma Cap Accum.Shs Exchage Traded Fund USD	52,200	Institution	0.01%	37,896
SPDR Portfolio Emerging Markets ETF	42,000	Institution	<0.01%	28,854
iShr Core EmrgMktIMI	34,200	Institution	<0.01%	33,891
iShares Core MSCI Emerging Markets IMI Index ETF Trust Units	34,200	Institution	<0.01%	33,891
SPDR S&P China ETF	32,200	Institution	<0.01%	22,121
iShares MSCI AC Far East ex-Japan SmallCap UCITS ETF USD	16,400	Institution	<0.01%	11,267

FAQ

Who Owns AIM Vaccine Co., Ltd. Class H (HK:6660)?

Currently, no data Available

What percentage of AIM Vaccine Co., Ltd. Class H (HK:6660) stock is held by institutional investors?

Currently, no data Available

What percentage of AIM Vaccine Co., Ltd. Class H (HK:6660) stock is held by retail investors?

According to the latest TipRanks data, approximately 99.57% of AIM Vaccine Co., Ltd. Class H (HK:6660) stock is held by retail investors.

Who owns the most shares of AIM Vaccine Co., Ltd. Class H (HK:6660)?

iShares owns the most shares of AIM Vaccine Co., Ltd. Class H (HK:6660).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing